Purebase appoints Dr. Kimberly Kurtis to board of directors as independent member

Purebase Corp

Dr. Kurtis appointed effective August 10, 2021; will receive $1,000 per month accruing as debt until first cash flow positive month.
Accrued director fees will be paid in shares at lower of $0.15/share or 20-day VWAP upon termination or resignation.
Granted 5-year option to purchase 200,000 shares at $0.36/share, exercisable after one year from August 13, 2021.
Dr. Kurtis brings expertise in supplementary cementitious materials; previously served as advisory board member.
Agreement automatically renews annually unless she gives 30 days' non-renewal notice.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Kimberly Kurtis

independent director

PUBC · Purebase Corp

Effective: 2021-08-10
Filed: August 17, 2021, 7:59 PM ET

Effective August 10, 2021, Dr. Kimberly Kurtis was appointed to serve on the Board of Directors of Purebase Corporation (the “Company”) as an independent member.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Kimberly Kurtis was appointed as independent director at Purebase Corp.

Action: appointed
Role: independent director

Exact text from the filing

Effective August 10, 2021, Dr. Kimberly Kurtis was appointed to serve on the Board of Directors of Purebase Corporation (the “Company”) as an independent member.

View on SEC.gov

Purebase Corp filing history →

Source: SEC EDGAR

accession 0001493152-21-020449

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.